Sweden · Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 35.86 billion. The enterprise value is 50.86 billion.
| Market Cap | 35.86B |
| Enterprise Value | 50.86B |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Medicover AB has 150.98 million shares outstanding. The number of shares has decreased by -2.16% in one year.
| Current Share Class | 74.36M |
| Shares Outstanding | 150.98M |
| Shares Change (YoY) | -2.16% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 11.16% |
| Owned by Institutions (%) | 25.93% |
| Float | 50.84M |
Valuation Ratios
The trailing PE ratio is 47.39 and the forward PE ratio is 34.41. Medicover AB's PEG ratio is 0.48.
| PE Ratio | 47.39 |
| Forward PE | 34.41 |
| PS Ratio | 1.40 |
| PB Ratio | 6.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.55 |
| P/OCF Ratio | 10.54 |
| PEG Ratio | 0.48 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.13, with an EV/FCF ratio of 27.73.
| EV / Earnings | 68.36 |
| EV / Sales | 1.98 |
| EV / EBITDA | 14.13 |
| EV / EBIT | 31.32 |
| EV / FCF | 27.73 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 2.74.
| Current Ratio | 0.78 |
| Quick Ratio | 0.68 |
| Debt / Equity | 2.74 |
| Debt / EBITDA | 4.38 |
| Debt / FCF | 8.60 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 11.98% and return on invested capital (ROIC) is 5.07%.
| Return on Equity (ROE) | 11.98% |
| Return on Assets (ROA) | 4.17% |
| Return on Invested Capital (ROIC) | 5.07% |
| Return on Capital Employed (ROCE) | 8.47% |
| Revenue Per Employee | 546,247 |
| Profits Per Employee | 15,831 |
| Employee Count | 47,256 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 28.16 |
Taxes
In the past 12 months, Medicover AB has paid 270.87 million in taxes.
| Income Tax | 270.87M |
| Effective Tax Rate | 28.06% |
Stock Price Statistics
The stock price has increased by +25.97% in the last 52 weeks. The beta is 1.57, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +25.97% |
| 50-Day Moving Average | 260.10 |
| 200-Day Moving Average | 239.02 |
| Relative Strength Index (RSI) | 23.58 |
| Average Volume (20 Days) | 61,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 25.67 billion and earned 744.05 million in profits. Earnings per share was 5.01.
| Revenue | 25.67B |
| Gross Profit | 5.91B |
| Operating Income | 1.62B |
| Pretax Income | 965.17M |
| Net Income | 744.05M |
| EBITDA | 2.66B |
| EBIT | 1.62B |
| Earnings Per Share (EPS) | 5.01 |
Balance Sheet
The company has 917.63 million in cash and 15.78 billion in debt, giving a net cash position of -14.86 billion or -98.41 per share.
| Cash & Cash Equivalents | 917.63M |
| Total Debt | 15.78B |
| Net Cash | -14.86B |
| Net Cash Per Share | -98.41 |
| Equity (Book Value) | 5.76B |
| Book Value Per Share | 37.13 |
| Working Capital | -1.48B |
Cash Flow
In the last 12 months, operating cash flow was 3.40 billion and capital expenditures -1.57 billion, giving a free cash flow of 1.83 billion.
| Operating Cash Flow | 3.40B |
| Capital Expenditures | -1.57B |
| Free Cash Flow | 1.83B |
| FCF Per Share | 12.15 |
Margins
Gross margin is 23.01%, with operating and profit margins of 6.32% and 2.90%.
| Gross Margin | 23.01% |
| Operating Margin | 6.32% |
| Pretax Margin | 3.76% |
| Profit Margin | 2.90% |
| EBITDA Margin | 10.35% |
| EBIT Margin | 6.32% |
| FCF Margin | 7.14% |
Dividends & Yields
This stock pays an annual dividend of 1.65, which amounts to a dividend yield of 0.68%.
| Dividend Per Share | 1.65 |
| Dividend Yield | 0.68% |
| Dividend Growth (YoY) | 17.10% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 33.43% |
| Buyback Yield | 2.16% |
| Shareholder Yield | 2.84% |
| Earnings Yield | 2.08% |
| FCF Yield | 5.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |